Searchable abstracts of presentations at key conferences in endocrinology

ea0099p298 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Current prevalence and patterns of hypolipidemic medication based on real-life nation-wide data on 10, 816, 286 individuals

Mathioudakis Konstantinos , Yavropoulou Maria , Evangelia Koloutsou Maria , Makras Polyzois , Liberopoulos Evangelos , Athanasakis Konstantinos

Background: Hypercholesterolemia has an established causal role in the progression of atherosclerosis and development of cardiovascular disease (CVD). In studies carried out after 2002, the estimated prevalence of self-reported dyslipidemia in the Greek population ranges from 11% to 23%, whereas approximately 35% of mortality in Greece is attributed to cardiovascular disease (CVD). Relevant real-life data, however, are scarce.Methods: In the present stud...

ea0099ep1290 | Late Breaking | ECE2024

Diagnosis of MEN-1 syndrome with multiple tumor locations and a rare genetic mutation

Tsitsimpis Anastasios , Papadimitriou Kasiani , Papanikolaou Vasiliki , Rigana Maria , Barkas Konstantinos , Nastos Konstantinos , Vryonidou Andromahi

Introduction: Most of pituitary adenomas are sporadic, with only 5% of them attributed to genetic mutations and syndromes such as Multiple Endocrine Neoplasia type 1 (MEN-1). However, how easy is it for a doctor to suspect it when there is no known family history?Case Presentation: A 36-year-old patient with no personal or family history presented to our Endocrine Department reporting intermittent episodes of unconsciousness during the last 48 hours. The...

ea0031p325 | Steroids | SFEBES2013

Dual role of TTC5 cofactor in GR-mediated gene expression

Sadeq Malihah , Demonacos Constantinos , Krstic-Demonacos Marija

Glucocorticoid receptor (GR) is a ligand-dependent nuclear receptor which regulates the transcription of a wide spectrum of genes that are responsible for vital immunological, metabolic, developmental, and anti-inflammatory functions. GR transcriptional regulatory effects are modulated by co-regulators including the tetratricopeptide 5 (TTC5) which has been shown to stabilize GR and alter its action in response to cellular stress. TTC5 is a stress-responsive activator of p300 ...

ea0020p233 | Bone/Calcium | ECE2009

Is parathyroid function abnormal in active acromegaly?

Tzioras Constantinos , Ioannidis George , Vrionidou Andromaxi

Introduction: Acromegaly is associated with skeletal changes that are characterized by appositional bone growth, increased bone dimensions and increased bone turnover. PTH is an important regulator of bone remodeling and its anabolic action requires the presence of GH. The strong correlation found between PTH concentrations and bone turnover markers in active and treated acromegaly has led to the suggestion, that the effect of GH on bone turnover may be mediated by PTH. Succes...

ea0077p118 | Thyroid | SFEBES2021

Cost-effectiveness analysis of liothyronine for the management of treatment unresponsive hypothyroidism based on latest evidence

Heald Adrian , Skiadas Konstantinos , Fitzsimmons Deborah , Anderson Pippa , Hughes Dyfrig

Introduction: Between 5-10% of patients with hypothyroidism treated with levothyroxine (T4) continue to experience profound symptoms, despite achieving free T4/thyroid stimulating hormone concentrations within reference range. Liothyronine is sometimes added to levothyroxine, but its use is controversial due to uncertainties in clinical/cost effectiveness.Methods: An economic model was developed to estimate the incremental cost per quality-adjusted life ...

ea0081oc1.2 | Oral Communications 1: Diabetes, Obesity, Metabolism and Nutrition 1 | ECE2022

Glucose control and mortality in critically Ill patients, based on real world evidence

Dafoulas George , Kalamaras Ilias , Votis Konstantinos , Bargiota Alexandra

Objective: Published results of reduced morbidity and mortality with tight Glycemic Control of critical patients could not be reproduced in large prospective trials. Glycemic goals according to current respective guidelines include a target blood glucose range 140-180 mg/dl, while lower blood glucose targets may be appropriate for some patients. This study aims to provide real world evidence to this field.Methods: We performed a retrospective study using...

ea0065p382 | Reproductive Endocrinology and Biology | SFEBES2019

An evaluation of the current clinical care pathway of patients referred to a large UK Tertiary Centre with suspected PCOS

Bajaj Mitali , Elhassan Yasir , Gleeson Helena , Manolopoulos Konstantinos

Background: PCOS is a common female endocrine disorder, exacerbated by obesity. International guidelines therefore suggest weight loss as first line management. This service evaluation assessed the care pathway of patients referred to Queen Elizabeth Hospital Birmingham (QEHB) with suspected PCOS. We aimed to assess the referral wait time, reason for referral, treatment offered, and weight management in clinic.Methods: We undertook a cross-sectional stud...

ea0038p191 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Hypercortisolaemia increases femoral adipose tissue blood flow but not net fatty acid release in vivo

Manolopoulos Konstantinos , Bujalska Iwona , Luzio Steve , Arlt Wiebke , Tomlinson Jeremy

Hypercortisolaemia (Cushing’s Syndrome) is characterised by abdominal fat accumulation and gluteofemoral fat loss. The mechanisms underpinning this fat mass redistribution are unknown. Adipose tissue blood flow (ATBF) and net fatty acid release rate (lipolysis) are important determinants of depot-specific fat mass. We hypothesized that hypercortisolaemia may result in increased femoral ATBF and lipolysis promoting gluteofemoral fat mass loss. We recruited nine healthy mal...

ea0035p847 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

TSH-secreting pituitary adenoma treated conservatively with cabergoline for more than 10 years

Mathiopoulou Monika , Bukowczan Jakub , Lois Konstantinos , Quinton Richard

Background: TSH secreting pituitary adenomas represent small proportion of functional pituitary tumours presenting as hyperthyroidism with elevated thyroid hormone levels and inappropriately normal or increased TSH concentration. They are ≥1 cm in size and quite aggressive with tendency to relapse following transphenoidal adenomectomy (TSA). Surgical resection remains gold standard in their definitive treatment while pharmacotherapy with long-acting somatostatin analogue...

ea0034p98 | Clinical practice/governance and case reports | SFEBES2014

Outcomes following pituitary surgery: a single centre audit

Manolopoulos Konstantinos , Bates Andrew S , Shad Amjad , Rahim Assad

Introduction: Pituitary surgery is associated with post-operative complications including hypopituitarism and visual field defects. In order to ensure that our surgical outcomes were comparable with other centres, we audited the outcome of a cohort of patients referred for surgery at a single centre.Methods: A retrospective audit of 27 consecutive patients diagnosed with pituitary adenoma at Heartlands Hospital Birmingham, who underwent trans-sphenoidal ...